HTG Molecular Diagnostics, Inc. - stock earnings
Stock symbol HTGM is outdated, potentially delisted? Maybe it is available on other exchange?
HTGM Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022Q3 | -4.5 million USD | 1.3 million USD |
| 2022Q2 | -5.9 million USD | 1.5 million USD |
| 2022Q1 | -6.5 million USD | 1.2 million USD |
| 2021Q4 | -5.2 million USD | 2.9 million USD |
| 2021Q3 | -4.5 million USD | 2.5 million USD |
| 2021Q2 | -2.6 million USD | 2.1 million USD |
| 2021Q1 | -4.8 million USD | 1.4 million USD |
| 2020Q4 | -4.3 million USD | 2.6 million USD |
| 2020Q3 | -5.4 million USD | 1.8 million USD |
HTGM Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2021 | -17.1 million USD | 8.9 million USD |
| 2020 | -20.9 million USD | 8.5 million USD |
| 2019 | -19.3 million USD | 19.2 million USD |
| 2018 | -16.5 million USD | 21.5 million USD |
| 2017 | -19.0 million USD | 14.8 million USD |
HTGM
Price: $0.48
52 week price:
Earnings Per Share: -1.06 USD
P/E Ratio: -0.90
Exchange: NCM
Sector: Healthcare
Industry: Diagnostics & Research
Volume: 1.3 million
Ebitda: -4.8 millionMarket Capitalization: 6.0 million